How has MRNA's revenue growth performed historically?
MRNA's revenue has grown faster (373.11% per year) than the US Biotechnology industry average (114.73%)
MRNA's revenue has grown faster (373.11% per year) than the US market average (16.83%)
MRNA earnings and revenue history
Current Profit Margin
MRNA Return on equity
MRNA's Return on Equity (19.8%) shows a company that is not efficient at transforming shareholder equity into returns
MRNA Return on assets
MRNA is generating higher Return on Assets (8.5%) than the US Biotechnology industry average (-8.77%)
MRNA Return on capital employed
MRNA earnings dates
Next earnings date
Aug 3, 2021
Moderna Earnings & Revenue FAQ
What were MRNA's earnings last quarter?
On May 06, 2021, Moderna (NASDAQ: MRNA) reported Q1 2021 earnings per share (EPS) of $3.05, up 971.43% year over year. Total Moderna earnings for the quarter were $1.22 billion. In the same quarter last year, Moderna's earnings per share (EPS) was -$0.35.
What was MRNA's earnings growth in the past year?
As of Q2 2021, Moderna's earnings has grown null year over year. Moderna's earnings in the past year totalled $598.17 million.
On May 06, 2021, Moderna (NASDAQ: MRNA) reported Q1 2021 revenue of $1.94 billion up 24,112.5% year over year. In the same quarter last year, Moderna's revenue was $8.00 million.
What was MRNA's revenue growth in the past year?
As of Q2 2021, Moderna's revenue has grown 5,135.33% year over year. This is 4,565.92 percentage points higher than the US Biotechnology industry revenue growth rate of 569.42%. Moderna's revenue in the past year totalled $2.73 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.